Arcus Biosciences (RCUS) Drops 5.9% to $22.80
Arcus Biosciences shares tumbled 5.3% on Monday to $22.97 after the company announced it is discontinuing its Phase 3 STAR-121 trial due to futility. The…
14 articles, transcripts, and reports
Arcus Biosciences shares tumbled 5.3% on Monday to $22.97 after the company announced it is discontinuing its Phase 3 STAR-121 trial due to futility. The…
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release
Arcus Biosciences, Inc (NYSE: RCUS) Sec Form 8K
Arcus Biosciences, Inc (RCUS) Q4 2025 Earnings Call Transcript. Complete management remarks and analyst Q&A. Read the full transcript here.
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Corporate Conference
Arcus Biosciences, Inc (NYSE: RCUS) Sec Form 10K
Arcus Biosciences, Inc (NYSE: RCUS) Sec Form 8K
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release